10 New Drugs for Primary Care: Q2 2017
Slide Show: FDA drug approvals in the second quarter 2017 included these 10 for conditions seen in the primary care setting.
HCV and Primary Care: A Special Report Recap
For PCPs, now poised to play a bigger role in screening and care for patients with HCV, we highlight 10 forces reshaping the HCV landscape.
Treatment Strategies to Limit Hypoglycemia
Studies summarized in this slide show focus on fine-tuning insulin-containing regimens to enhance glucose control and avoid variability.
ADA 2017: Hypoglycemia and the Role of Glycemic Variability
Glycemic variability fuels hypoglycemia but in one study from ADA 2017 is found to actually help predict hypoglycemic events.
ADA 2017: Evaluating Cardiovascular Safety of Antidiabetic Agents
Cardiovascular risk/benefit profiles of pioglitazone and the SGLT2 inhibitor class are summarized, based on reports at ADA 2017.
ADA 2017: CV Complications of Diabetes
A1C vs FPG to diagnose prediabetes; prediabetes and CHF; and how much weight loss is too much? Reports from ADA 2017.
ADA 2017: Oral Agents Under Review
When to start screening for B12 deficiency in your diabetes patients taking metformin? We review a dose-response diet study plus 2 others on oral drugs.
ADA 2017: Insulins go Head-to-Head
Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017.
Climate Change Is a Health Hazard: 8 Examples
Increases in diabetes, insomnia, and skin cancer are just 3 of the hazardous trends identified in recent research. More findings in our slide show.
5 Top Hypertension Apps for Primary Care
Have a quick look at 5 apps that track BP, estimate risk, chart DASH, just say "Ohm," and more.
By clicking Accept, you agree to become a member of the UBM Medica Community.